Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008526713-A |
titleOfInvention |
Compounds useful for the treatment of HIV |
abstract |
To treat HIV infection where HIV reverse transcriptase has at least one mutation that allows absolute chain-terminating nucleoside- or nucleotide phosphates to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision Use of 2 ′, 3′-dideoxy-3′-hydroxymethylcytosine or a prodrug or a salt thereof in the manufacture of |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021073214-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510892-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304906-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11395801-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279669-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746081-B2 |
priorityDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |